Completed PHASE2 INTERVENTIONAL NCT00000347

Risperidone for Treatment of Cocaine Dependence in Outpatients - 12

Risperidone for Treatment of Cocaine Dependence in Outpatients

Sponsor: National Institute on Drug Abuse (NIDA)

Interventions Risperidone

Updated 6 times since 2017 Last updated: Jan 11, 2017 Started: Jul 31, 1997 Primary completion: Aug 31, 1998 Completion: Sep 30, 1998

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00000347, this PHASE2 trial focuses on Cocaine-Related Disorders and remains completed. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 6 times since 1997, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Jul 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)

Data source: National Institute on Drug Abuse (NIDA)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Los Angeles, United States